2024 Syneos health sale - ipopba/iStock via Getty Images Syneos Health ( NASDAQ: SYNH) jumped 14% on a report that a handful of private equity firms are said to be interested in the …

 
August 11, 2023 at 8:53 AM · 4 min read. Syneos Health SYNH recently announced that its stockholders have approved the company’s merger agreement with a private investment consortium at a .... Syneos health sale

From 2008 to 2021, Mr. Bonello held roles of increasing responsibility at Nasdaq-listed PRA Health Sciences, Inc., including Executive Vice President and Chief Financial Officer from 2018 through ...Syneos Health, a North Carolina-based biopharma contract research organization, agreed to be taken private for $7.1 billion by an investor group that includes Elliott Investment Management, Patient Square Capital and Veritas Capital. ... More, per Reuters: "Syneos has been facing challenges in winning new business, as many of its …Walking and running are both great forms of aerobic exercise — and they both come with great health benefits. Regularly walking or running can strengthen your bones, heart and lungs and help you stay at a healthy weight. But there are some ...Taking care of your mental health is equally as important as taking care of your physical health. Those living with a mental illness or disorder — whether ongoing or temporary — often find that it affects many areas of their life, including...LightRocket via Getty Images. Shares of Syneos Health (SYNH) gained more than 9% today after the company reported better-than-expected results for the final quarter of 2022 this morning ...11 de out. de 2023 ... Search 1 Sales Careers in Hamilton available. View and apply to Sales positions.Feb 27, 2023 · Feb 27 (Reuters) - Syneos Health Inc (SYNH.O) is making a new effort to sell itself after a reduced backlog of contracts for providing clinical research to drug developers led to a 52% plunge... Syneos Health has launched more sales teams in the last 5 years across all major therapeutic areas than the top 25 pharma companies combined. Join our game-changing, global company dedicated to ...11 de out. de 2023 ... Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique ...Analysts are somewhat split on Syneos Health stock in general. Currently, analyst consensus calls it a Hold based on one Buy, three Holds, and two Sells. In addition, its average price target of ... Syneos Health ® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. Together we share insights, use the latest technologies and apply advanced business practices to speed our …Simply Lemon is a popular brand of lemon juice that has been gaining popularity in recent years. Not only is it a convenient way to add flavor to your drinks and dishes, but it also has numerous health benefits.May 10, 2023 · They will acquire the North Carolina-based firm for $43 per share in cash, a 24% premium to its last close before news of a potential sale emerged in February. Story continues below. The deal, which values Syneos at $7.1 billion including debt, adds to a wave of transactions involving companies that support drug development. The announcement of the Syneos Health sale comes nearly six years after Syneos Health was created by the $7.4 billion merger of INC Research and inVentiv Health in August 2017. Here's a detailed ...Syneos Health, Inc. (SYNH.NYSE) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Syneos Health, Inc. | Nyse: SYNH | Nyse.May 10, 2023 · A group of investors, including Elliott Investment Management, Patient Square Capital, and Veritas Capital, is close to acquiring Syneos Health Inc (NASDAQ: SYNH) for more than $7 billion ... Santa Monica, CA. GSW is part of Syneos Health Communications, a purpose-built collective of agencies focused on supporting health and biopharmaceutical innovators. We work in scalable, collaborative teams that partner across disciplines and geographies to deliver integrated communications strategies that accelerate brand …Feb 27 (Reuters) – Syneos Health Inc. (SYNH.O) is making a new effort to sell itself after a reduced backlog of contracts for providing clinical research to drug developers led to a 52% plunge in its shares over the past year, according to people familiar with the matter. Reuters reported in March 2020 that Syneos was working with …May 10, 2023, 8:02 am EDT Reprints Syneos Health shares rose Wednesday after it agreed to a sale to a consortium of private investors. The sale comes after a tough period for the...11 de out. de 2023 ... Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique ...3 de out. de 2023 ... ... sale to Icon in 2021. In addition to his time at PRA, Shannon held leadership roles at Pharmaceutical Product Development, another contract ...Shares of Syneos Health Inc rose 13% after Reuters exclusively reported that the company is making a new effort to sell itself. The effort comes in the wake of a …LOS ANGELES, Sept. 14, 2023 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit ...May 19, 2023 · The announcement of the Syneos Health sale comes nearly six years after Syneos Health was created by the $7.4 billion merger of INC Research and inVentiv Health in August 2017. Here's a detailed ... When someone picks up a cigarette for the first time, it’s often to satisfy a curiosity, to look cool or to succumb to peer pressure. If people consider the numerous dangers to their health that smoking can cause, they may think twice about...Health insurance is a necessity, but finding a suitable insurance plan that offers the coverage you need, and that is kind to your pocketbook, can be quite a hassle. Let’s take a look at what to know about affordable insurance and where to ...LightRocket via Getty Images. Shares of Syneos Health (SYNH) gained more than 9% today after the company reported better-than-expected results for the final quarter of 2022 this morning ...The announcement of the Syneos Health sale comes nearly six years after Syneos Health was created by the $7.4 billion merger of INC Research and inVentiv Health in August 2017. Here's a detailed ...Feb 27 (Reuters) - Syneos Health Inc (SYNH.O) is making a new effort to sell itself after a reduced backlog of contracts for providing clinical research to drug developers led to a 52% plunge...May 10, 2023, 8:02 am EDT Reprints Syneos Health shares rose Wednesday after it agreed to a sale to a consortium of private investors. The sale comes after a tough period for the...Syneos Health is committed to making every job professionally and financially rewarding. To help meet this commitment, we offer the following: Compensation Competitive global total compensation program. Retirement Syneos Health 401 (k) plan and company match. Insurance Life, Travel, Accidental Death & Dismemberment, and Short-term and Long …Key Insights. Using the 2 Stage Free Cash Flow to Equity, Syneos Health fair value estimate is US$67.23. Syneos Health is estimated to be 41% undervalued based on current share price of US$39.69 ...Sep 27, 2023 · Syneos Health, Inc. is a biopharmaceutical solutions company that utilizes outsourced clinical drug development and commercialization services. The Company operates through two business segments: Clinical Solutions and Commercial Solutions. 11 de mai. de 2023 ... Syneos Health SYNH recently entered into a definitive agreement to be acquired by a private investment consortium in an all-cash transaction ...We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. To learn more about how we are Shortening the distance from lab to life®, visit syneoshealth.com. Morrisville, NC 27560. Phone: 919 876 9300 Fax: 919 876 9360 Toll-Free: 866 462 7373.The Company and Syneos Health caution you that any such forward-looking statements are further qualified by important factors that could cause the Company and Syneos Health’s actual operating ...Feb 27, 2023 · Reuters reported in March 2020 that Syneos was working with investment bank Centerview Partners LLC to explore a sale. The market disruption triggered by the onset of the COVID-19 pandemic prompted Syneos to abandon those sale deliberations, according to four sources familiar with the discussions. From 2008 to 2021, Mr. Bonello held roles of increasing responsibility at Nasdaq-listed PRA Health Sciences, Inc., including Executive Vice President and Chief Financial Officer from 2018 through ...Syneos Health Inc. is exploring a sale of its business, with potential bidders including IQVIA Holdings Inc. and PRA Health Sciences Inc., Reuters reported March 9, citing people familiar with the matter. The Morrisville, N.C.-based contract research organization is soliciting acquisition offers from private equity firms and other companies ...SYNEOS HEALTH INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Syneos Health, Inc. - SYNH May 10 ...Transaction Will Drive Ongoing Transformation and Accelerate Delivery of Tech-Enabled, Fit-for-Purpose Solutions to Biopharma CustomersMORRISVILLE, N.C., Sept. 28, 2023 (GLOBE NEWSWIRE) -- Syneos ...Average Syneos Health Commercial Solutions Pharmaceutical Sales Representative yearly pay in the United States is approximately $71,929, which meets the national average. Salary information comes from 155 data points collected directly from employees, users, and past and present job advertisements on Indeed in the past 36 months.Arlington, Virginia-based Evolent Health Inc. is charting its new growth trajectory after it opened the year by laying off more than 460 employees. The company will look to build up by integrating ...Syneos Health (NASDAQ:SYNH) may be worth toward the midpoint of a range of $40-$53 a share, according to a Barclays analyst. ... Reuters reported in March 2020 that Syneos was exploring a sale ...Syneos. by Rick Smith — September 29, 2023. MORRISVILLE – Syneos Health is now a private company, having wrapped up its deal valued at some $7 billion with private equity partners Elliott ...We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. To learn more about how we are Shortening the distance from lab to life®, visit syneoshealth.com. Morrisville, NC 27560. Phone: 919 876 9300 Fax: 919 876 9360 Toll-Free: 866 462 7373.Reuters. (Reuters) -An investment consortium, comprising of Elliott Investment Management, Patient Square Capital and Veritas Capital, has agreed to take Syneos Health Inc private for $4.46 ...Our product launch strategies will give you a strategic advantage while we help expedite and augment your commercial go-to-market strategy to meet new market realities. Results and Performance: More experience creating field teams that meet or exceed customer-driven metrics and goals by creating a custom designed drug launch strategy to fit ...Feb 27 (Reuters)-Syneos Health Inc SYNH.O is making a new effort to sell itself after a reduced backlog of contracts for providing clinical research to drug developers led to a 52% plunge in its shares over the past year, according to people familiar with the matter.Syneos Health will host a conference call at 8:00 a.m. ET on February 18, 2021, to discuss its fourth quarter and full year 2020 financial results. The live webcast will be available in listen ...Syneos Health, a global contract research organization (CRO) headquartered in Morrisville, will likely be sold to a consortium of private investment firms in a deal valued at $7.1 billion.. The publicly traded company has signed a definitive agreement to be taken private by Elliott Investment Management, Patient Square Capital and …Feb 27, 2023 · Exclusive-Syneos Health eyes sale of company as contract backlog shrinks-sources. (Reuters) – Syneos Health Inc is making a new effort to sell itself after a reduced backlog of contracts for providing clinical research to drug developers led to a 52% plunge in its shares over the past year, according to people familiar with the matter ... If you feel like you are unable to care for your elderly loved ones on your own or want to enable them to stay at home as long as possible, you should explore home health care. Here’s what you need to know about the costs of home health car...The average Syneos Health Commercial Solutions salary ranges from approximately $80,339 per year for an Inside Sales Representative to $216,906 per year for an Account Director. The average Syneos Health Commercial Solutions hourly pay ranges from approximately $45 per hour for a Recruiter to $45 per hour for a Recruiter. …Santa Monica, CA. GSW is part of Syneos Health Communications, a purpose-built collective of agencies focused on supporting health and biopharmaceutical innovators. We work in scalable, collaborative teams that partner across disciplines and geographies to deliver integrated communications strategies that accelerate brand …CFRA has downgraded contract research organization Syneos Health ( NASDAQ: SYNH) to hold on a potential risk to margins caused by share-based compensation and restructuring costs. The firm also ...Reuters. (Reuters) -An investment consortium, comprising of Elliott Investment Management, Patient Square Capital and Veritas Capital, has agreed to take Syneos Health Inc private for $4.46 ...Sep 28, 2023 · Under the terms of the transaction, Syneos Health stockholders will receive $43.00 in cash for each share of Syneos Health common stock they hold (without interest and subject to any applicable ... Syneos Health ( NASDAQ: SYNH) may be worth toward the midpoint of a range of $40-$53 a share, according to a Barclays analyst. The analysis comes after after a Monday report that the contract ...Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical …May 10, 2023 · May 10 (Reuters) - An investment consortium, comprising of Elliott Investment Management, Patient Square Capital and Veritas Capital, has agreed to take Syneos Health Inc (SYNH.O) private for... Mar 27, 2022 · Syneos Health ( NASDAQ: SYNH) was formed via the merger of 2 Contract Research Organisations ("CROs") with complementary businesses, INC Research and inVentiv Health in 2017, and although it took ... Syneos Health has helped to develop or commercialize 92% of novel new drugs approved by the FDA in a recent five-year period. Here, we translate unique clinical, medical affairs and commercial insights to address modern market realities. ... AD/Director, BD Sponsor Sales (Required to be located or work in PST) Location: United States-North ...May 10, 2023, 8:02 am EDT Reprints Syneos Health shares rose Wednesday after it agreed to a sale to a consortium of private investors. The sale comes after a tough period for the...Feb 27, 2023 · Reuters reported in March 2020 that Syneos was working with investment bank Centerview Partners LLC to explore a sale. The market disruption triggered by the onset of the COVID-19 pandemic prompted Syneos to abandon those sale deliberations, according to four sources familiar with the discussions. 30d+. Syneos Health. Sr Medical Writer (Publication) United States. $61K - $155K (Employer est.) 7d. Syneos Health. Sr Analytical Scientist (Bioanalytical, 3-5yr Exp) Princeton, NJ.Jun 7, 2023 · From shareholders’ perspective, the sale price represents a 24% premium to Syneos Health’s unaffected closing stock price on Feb 13, 2023, the last trading day prior to media speculation ... The safety and well-being of our babies is a top priority for every parent. With advancements in technology, monitoring devices like the Owlet Baby Monitor have become an essential tool for parents to ensure their baby’s health and safety.MORRISVILLE, N.C., May 10, 2023 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH) (“Syneos Health” or the “Company”), a leading fully …Search 3 Sales Careers in Austin available. View and apply to Sales positions.A group of investors, including Elliott Investment Management, Patient Square Capital, and Veritas Capital, is close to acquiring Syneos Health Inc (NASDAQ: SYNH) for more than $7 billion ...They sold control of it to a consortium of private equity firms in a $17 billion deal in 2021. Patient Square Capital is a health-care focused private equity firm started in 2020 by Momtazee ...Whether you’re in perfect health or searching for catastrophic coverage, the best health plans in New York have you covered. Choose a small group health plan or company health plans, or work with health plan brokers to capture the coverage ...SYNH. for more than $7 billion, including debt. Bloomberg News first reported the news of the investment consortium's talks with Syneos. The consortium will pay about $43 per share in cash for ...6 years ago Argus Research. SYNH: Lowering target price to $53.00 SYNEOS HEALTH INC has an Investment Rating of HOLD; a target price of $53.00; an Industry Subrating of High; a Management ...https://www.syneoshealth.com. Syneos Health, Inc., operates as an integrated biopharmaceutical solutions company. The company operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, devices, and digital …Syneos Health Inc <SYNH.O>, a U.S. contract research organization (CRO) that serves the pharmaceutical industry, is exploring a sale, people familiar with the matter said on Monday.Mar 9, 2020 · Syneos shares were trading down 30% because of the stock market rout before the Reuters story on Monday, but jumped on the news of the possible sale to trade up 1.7% at $65.60, giving it a market ... 6 de set. de 2023 ... If the sale of the Notes is not completed concurrently with the closing of the Acquisition, then the proceeds from the sale of the Notes will be ...Analysts are somewhat split on Syneos Health stock in general. Currently, analyst consensus calls it a Hold based on one Buy, three Holds, and two Sells. In addition, its average price target of ... Syneos Health (formerly InVentiv Health Incorporated and INC Research) is an American company that provides contract research and commercial services to pharmaceutical and biotechnology companies. Based in Morrisville, North Carolina , the company specializes in helping other companies with late-stage clinical trials, but also provides ...Syneos Health, Inc. (NASDAQ:SYNH) released its earnings results on Wednesday, November, 3rd. The company reported $1.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.17 by $0.05. The company had revenue of $1.35 billion for the quarter, compared to analysts' expectations of $1.34 billion.Feb 27 (Reuters) - Syneos Health Inc SYNH.O is making a new effort to sell itself after a reduced backlog of contracts for providing clinical research to drug …December 10, 2020 08:59 ET | Source: Syneos Health, Inc. MORRISVILLE, N.C., Dec. 10, 2020 (GLOBE NEWSWIRE) -- Syneos Health ® (Nasdaq: SYNH ), the only fully integrated biopharmaceutical ...Syneos health sale

The latest word from Dealreporter suggests that’s the case and that there are a growing number of firms coming in to take a shot at buying Syneos outright. The news was more than enough to draw investor attention, as Syneos is up over 10% at the time of writing. The aforementioned reports note that, right now, four different parties—and .... Syneos health sale

syneos health sale

We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. To learn more about how we are Shortening the distance from lab to life®, visit syneoshealth.com . 1030 Sync Street Morrisville, NC 27560. Phone: 919 876 9300 Fax: 919 876 9360 Toll-Free: 866 462 7373.10 de mar. de 2023 ... ... Syneos Health's use of debt. This suggests shareholders would be heavily ... It does not constitute a recommendation to buy or sell any stock ...May 10, 2023 · Information regarding Syneos Health’s directors and executive officers is contained in Syneos Health’s Annual Report on Form 10-K/A for the year ended December 31, 2022, filed with the SEC on ... Syneos Health ( NASDAQ: SYNH) may be worth toward the midpoint of a range of $40-$53 a share, according to a Barclays analyst. The analysis comes after after a Monday report that the contract ...As the largest and longest-tenured US provider of outsourced sales, we are leaders in modern customer engagement – and continue to refine and redefine it ...EXCLUSIVE-Syneos Health eyes sale of company as contract backlog shrinks-sources. Feb 27 (Reuters) - Syneos Health Inc is making a new effort to sell itself after a reduced backlog of contracts ...Sep 11, 2023 · NEW YORK, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Syneos Health, Inc. ( Syneos shares were trading down 30% because of the stock market rout before the Reuters story on Monday, but jumped on the news of the possible sale to trade up 1.7% at $65.60, giving it a market ...Building High Performing Life Science Sales and Commercial Teams. ... TSP is proud to be a member of the Syneos Health® family. With our unmatched scalability, we can lean into nearly 30,000 minds and unique skill sets to ensure excellent delivery. On their own or seamlessly blended, our teams deliver talent solutions that fuel your growth. ...Iryna Drozd. Reported private equity interest in Syneos Health. On Monday (April 10th), Dealreporter put out an article that at least four parties are in the second round of a sale process ...Syneos Health ( NASDAQ: SYNH) may be worth toward the midpoint of a range of $40-$53 a share, according to a Barclays analyst. The analysis comes after after a Monday report that the contract ...Syneos Health has launched more sales teams in the last 5 years across all major therapeutic areas than the top 25 pharma companies combined. Join our game-changing, global company dedicated to creating better, smarter, faster ways to get biopharmaceutical therapies to patients. Experience the thrill of knowing that your everyday efforts are ...10 de mar. de 2023 ... ... Syneos Health's use of debt. This suggests shareholders would be heavily ... It does not constitute a recommendation to buy or sell any stock ...Syneos shares were trading down 30% because of the stock market rout before the Reuters story on Monday, but jumped on the news of the possible sale to …Your health is more important than anything else. A healthy person can keep earning money so always put your health ahead of your financial needs. Don’t make the mistake of thinking that you’re too young to consider your health care needs.We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. To learn more about how we are Shortening the distance from lab to life®, visit syneoshealth.com. Morrisville, NC 27560. Phone: 919 876 9300 Fax: 919 876 9360 Toll-Free: 866 462 7373.11 de out. de 2023 ... Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique ...Sep 28, 2023 · Transaction Will Drive Ongoing Transformation and Accelerate Delivery of Tech-Enabled, Fit-for-Purpose Solutions to Biopharma Customers. MORRISVILLE, N.C., Sept. 28, 2023 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (“Syneos Health” or the “Company”), a leading fully integrated biopharmaceutical solutions organization, today announced the completion of its acquisition by a consortium of ... Analysts are somewhat split on Syneos Health stock in general. Currently, analyst consensus calls it a Hold based on one Buy, three Holds, and two Sells. In addition, its average price target of ... Syneos Health has launched more sales teams in the last 5 years across all major therapeutic areas than the top 25 pharma companies combined. Join our game-changing, global company dedicated to creating better, smarter, faster ways to get biopharmaceutical therapies to patients. Experience the thrill of knowing that your everyday efforts are ...Syneos Health has launched more sales teams in the last 5 years across all major therapeutic areas than the top 25 pharma companies combined. Join our game-changing, global company dedicated to creating better, smarter, faster ways to get biopharmaceutical therapies to patients. Experience the thrill of knowing that your …Our product launch strategies will give you a strategic advantage while we help expedite and augment your commercial go-to-market strategy to meet new market realities. Results and Performance: More experience creating field teams that meet or exceed customer-driven metrics and goals by creating a custom designed drug launch strategy to fit ... Syneos shares were trading down 30% because of the stock market rout before the Reuters story on Monday, but jumped on the news of the possible sale to trade up 1.7% at $65.60, giving it a market ...Sep 28, 2023 · Transaction Will Drive Ongoing Transformation and Accelerate Delivery of Tech-Enabled, Fit-for-Purpose Solutions to Biopharma Customers. MORRISVILLE, N.C., Sept. 28, 2023 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (“Syneos Health” or the “Company”), a leading fully integrated biopharmaceutical solutions organization, today announced the completion of its acquisition by a consortium of ... benzinga.com - September 22 at 1:35 PM. SG Americas Securities LLC Has $2.23 Million Stock Position in Syneos Health, Inc. (NASDAQ:SYNH) marketbeat.com - September 22 at 4:34 AM. Here’s Why ClearBridge Investments Small Cap Strategy Sold Syneos Health (SYNH) finance.yahoo.com - September 18 at 2:29 PM.Syneos Health ® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. Together we share insights, use the latest technologies and apply advanced business practices to speed our …May 10, 2023 · Reuters. (Reuters) -An investment consortium, comprising of Elliott Investment Management, Patient Square Capital and Veritas Capital, has agreed to take Syneos Health Inc private for $4.46 ... Dive Brief: Syneos Health, a leading biopharmaceutical contract research organization, agreed to be acquired for $7.1 billion by a group of private equity firms. Elliott Investment Management, Patient Square Capital and Veritas Capital will take on outstanding debt plus pay $43 a share for Syneos, according to terms released Wednesday.The purchase price represents a 24% premium to Syneos Health's unaffected closing stock price of $34.65 on February 13, 2023, the last trading day prior to media speculation regarding the Company.Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, ...Syneos Health ® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. Together we share insights, use the latest technologies and apply advanced business practices to speed our …Elliott Investment Management, Patient Square Capital and Veritas Capital are offering to take-private contract-research organization Syneos Health for $43 a share in cash in a transaction valued ...30d+. Syneos Health. Sr Medical Writer (Publication) United States. $61K - $155K (Employer est.) 7d. Syneos Health. Sr Analytical Scientist (Bioanalytical, 3-5yr Exp) Princeton, NJ.May 10, 2023 · And it's not just within health care, with firms said to be clubbing up for sandwich shop chain Subway. Details: Syneos shareholders will receive $43 per share in cash, which represents a 12% premium to Tuesday's closing price and a 24% premium to the Feb. 13 price before new reports that Syneos was seeking a buyer. See Total Pay Breakdown below. The estimated total pay for a Pharmaceuticals Sales Representative at Syneos Health is $162,939 per year. This number represents the median, which is the midpoint of the ranges from our proprietary Total Pay Estimate model and based on salaries collected from our users. The estimated …May 3, 2023 · 2 years after merger, Syneos Health 'exploring a sale': report. Bonello boasts more than 30 years of experience in the financial arena—including 15 years in the CRO field. He was recently CFO at ... Syneos Health, a global contract research organization (CRO) headquartered in Morrisville, will likely be sold to a consortium of private investment firms in a deal valued at $7.1 billion. The publicly traded company has signed a definitive agreement to be taken private by Elliott Investment Management, Patient Square Capital and Veritas ...SYNH. for more than $7 billion, including debt. Bloomberg News first reported the news of the investment consortium's talks with Syneos. The consortium will pay about $43 per share in cash for ...This statistic depicts the yearly revenue, globally, for Syneos Health, Inc. from 2013 to 2022. Syneos Health is a biopharmaceutical contract research organization that operates globally. In 2022 ...2 years after merger, Syneos Health 'exploring a sale': report By Ben Adams Mar 10, 2020 7:55am Biotech Stock mergers and acquisitions Syneos Health It’s been just over two years since INC...SYNH - Syneos Health Inc - Class A Stock - Stock Price, Institutional Ownership, Shareholders (NASDAQ)Drug trials company Syneos to be acquired for $7.1 billion. Syneos Health, a North Carolina-based biopharma contract research organization, agreed to be taken private for $7.1 billion by an investor group that includes Elliott Investment Management, Patient Square Capital and Veritas Capital. Why it matters: Private equity firms are once again ...Technology is rapidly improving and changing every aspect of the world, including health care. The same changes that led to huge improvements in fields like business or the sciences have also made treating patients easier and more effective...May 10, 2023 · 2:56. A consortium backed by Elliott Investment Management agreed to buy drug-research services company Syneos Health Inc. for about $4.4 billion. Sure, your fingernails might require a lot of upkeep, but did you know that they can actually tell you a lot about your health? While the look or texture of your fingernails isn’t a surefire way to diagnose all conditions, their appearance ...Syneos Health received an acquisition offer from a PE consortium of c.$7.1 billion. The transaction involves an all-cash consideration of $43.00 per share, a 1.7% premium over SYNH's stock price ...The company’s recent decision to sell itself seems strategic. Syneos Health operates in a strict regulatory environment, which is a concern. The stock carries a Zacks Rank #3 (Hold).Reuters reported in March 2020 that Syneos was working with investment bank Centerview Partners LLC to explore a sale. The market disruption triggered by the onset of the COVID-19 pandemic prompted Syneos to abandon those sale deliberations, according to four sources familiar with the discussions.Feb 27 (Reuters) - Syneos Health Inc is making a new effort to sell itself after a reduced backlog of contracts for providing clinical research to drug developers led to a 52% plunge in its shares over the past year, according to people familiar with the matter.. Interior sewer line insurance